Clinical Trial Update: FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer [Phase 1, Phase 2]

View source ↗

Summary

ClinicalTrials.gov update describes a Phase 1/2 trial of FOR46 in combination with enzalutamide for metastatic castration-resistant prostate cancer, currently a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer
• Prostate Cancer

Drugs mentioned

• Enzalutamide (enzalutamide)
• FOR46

Snippet

Sponsor: Rahul Aggarwal | Conditions: Metastatic Castration-resistant Prostate Cancer, Prostate Cancer | Phase 1, Phase 2 | Status: ACTIVE_NOT_RECRUITING